Historique
Auteur R. SEDEFOV
Documents disponibles écrits par cet auteur (45)
Ajouter le résultat à votre sélection Affiner la recherche
A. M. DINES ; D. M. WOOD ; C. YATES ; F. HEYERDAHL ; K. E. HOVDA ; I. GIRAUDON ; R. SEDEFOV ; P. I. DARGAN ; Euro-DEN Research Group | 2015
Dans Clinical Toxicology (Vol.53, n°9, November 2015) Article : PériodiqueCONTEXT: Despite the potential for recreational drugs and new psychoactive substances (NPSs) to cause significant morbidity and mortality, there is limited collection of systematic data on acute drug/NPS toxicity in Europe. OBJECTIVE: To report[...]
Europol ; L. LANIEL ; C. CARPENTIER ; J. MOUNTENEY ; B. PALLAVICINI ; L. ROYUELA ; J. MATIAS ; R. KASECKER ; R. SEDEFOV ; P. GRIFFITHS | 2011
RapportFRANÇAIS : L'OEDT et Europol publient une analyse conjointe concernant le marché des amphétamines. Leader dans la production des amphétamines, l'Europe est également une zone importante de consommation. ENGLISH: This joint publication with [...]
S. ELLIOTT ; R. SEDEFOV ; M. EVANS-BROWN | 2018
Dans Drug Testing and Analysis (Vol.10, n°1, January 2018) Article : PériodiqueThe number of new psychoactive substances (NPS) has increased significantly, especially within the last 5 years. The EMCDDA conducts risks assessments of such substances, especially in relation to serious adverse events. Examination of the indiv[...]
This report examines the role of Europe in the production and trafficking of captagon tablets. It includes an historical background, current production and trafficking, seizures, the consumer market, production within the EU, forensic analysis a[...]
OEDT = EMCDDA ; L. LANIEL ; M. GANDILHON ; J. E. ADES ; A. CUNNINGHAM ; N. SINGLETON ; R. SEDEFOV ; P. GRIFFITHS | 2018
RapportCaptagon is reported to be a commonly used stimulant in the Middle East. In addition, some recent media reports have linked this drug to perpetrators of terrorist acts in Europe or terrorist groups based in areas of conflict in the Middle East. [...]
J. HILLEBRAND ; D. OLSZEWSKI ; R. SEDEFOV ; B. HUGHES | 2007
Dans Objectif drogues (n°15, Juin 2007) Article : PériodiqueFRANÇAIS : Au cours de la dernière décennie, l'intérêt porté par les médias à la consommation de champignons hallucinogènes semble avoir été motivé par la libre commercialisation de ces champignons et par les réformes juridiques engagées dans [...]
Europol ; L. LANIEL ; C. CARPENTIER ; C. COSTA STORTI ; A. GALLEGOS ; D. LOPEZ ; C. MARTEL ; L. ROYUELA ; R. SEDEFOV ; R. SIMON ; J. WRIGHT ; F. ZOBEL ; P. GRIFFITHS | 2010
RapportThis report provides an overview of what is known about how cocaine is produced and trafficked into the European Union. It aims to provide a better understanding of the actors involved, the routes taken, and the scale of the problem in Europe. I[...]
F. HEYERDAHL ; K. E. HOVDA ; I. GIRAUDON ; C. B. YATES ; A. M. DINES ; R. SEDEFOV ; D. M. WOOD ; P. I. DARGAN | 2014
Dans Clinical Toxicology (Vol.52, n°10, December 2014) Article : PériodiqueBACKGROUND: The number of new (novel) psychoactive substances (NPS) available in the illegal market is increasing; however, current monitoring of the drug situation in Europe focuses mainly on classical drugs of abuse, with limited emphasis on c[...]
OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | 2019
RapportENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]Nouveauté
T. GROSHKOVA ; A. CUNNINGHAM ; L. ROYUELA ; N. SINGLETON ; T. SAGGERS ; R. SEDEFOV | 2018
Dans International Journal of Drug Policy (Vol.56, June 2018) Article : PériodiqueBackground: The importance of illicit drug price data and making appropriate adjustments for purity has been repeatedly highlighted for understanding illicit drug markets. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has [...]Nouveauté
N. SINGLETON ; A. CUNNINGHAM ; T. GROSHKOVA ; L. ROYUELA ; R. SEDEFOV | 2018
Dans International Journal of Drug Policy (Vol.56, June 2018) Article : PériodiqueInterventions to tackle the supply of drugs are seen as standard components of illicit drug policies. Therefore drug market-related administrative data, such as seizures, price, purity and drug-related offending, are used in most countries for p[...]
OEDT = EMCDDA ; E. QUIGLEY ; R. SEDEFOV ; C. CARPENTIER ; L. LANIEL ; European Commission, COWI Consortium for DG Health and Consumers | 2013
RapportThe production and trafficking of illicit drugs poses complex and interlinked problems, which have a negative impact on public health and the security and stability of society. Focusing on actions directed at the EU's internal security situation[...]
This publication presents 30 profiles of the national early warning systems on new psychoactive substances in operation in Europe in 2011. The early warning system on new psychoactive substances is a multidisciplinary network consisting of 30 Eu[...]
ENGLISH : The purpose of these guidelines is to address the measures introduced by Council Decision 2005/387/HA. They are concerned only with the first stage, i.e. the early-warning system and information exchange, and replace the earlier guid[...]
A. GOOSDEEL ; P. GRIFFITHS ; H. BERGERON ; M. NILSON ; D. HEDRICH ; R. SEDEFOV | 2003
Dans Objectif drogues (n°8, Mars 2003) Article : PériodiqueFRANÇAIS : Cet exposé fait le point sur les informations disponibles sur la situation en matière de drogues dans l'Union élargie et propose des références sources pour ceux qui veulent approfondir la question. Les conclusions qui suivent résum[...]
